Erickson: Product Roadmaps Should Balance Core Strengths with Long-Tail User Fixes
Daniel Erickson · 20VC: How To Scientifically Measure Product-Market Fit, How To Efficiently and Accurately Segment Users Into Cohorts, Why Investors Analysing CAC's at Pre-Seed Is Not Useful & How To Determine Between Customer Feedback to Accept vs Reject with Daniel Eric · Jun 5, 2020 · at 5:10
Daniel Erickson, founder of Viable Fit, outlines product roadmap design principles for optimizing continuous product-market fit.
0:00 / 0:12exact quote · 12.3s
720p mp4 · rendered on demand · StarZero watermark
“Your roadmap should be automatically prioritized as you come up with project ideas, and it should help you strike a balance between investing in your strengths and working on the long tail of features and fixes that will help turn less enthusiastic customers into fanatical supporters.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Daniel Erickson
Erickson: Seed stage is definitely too early to measure CAC and LTV
“So in my opinion, at least, seed stage is definitely too early to start measuring CAC and LTV, but they're still super important to keep in mind.”
Erickson: Google and Zoom succeeded by building faster horses
“Sometimes users want a faster horse. Google and Zoom are both great examples of that.”
Erickson: Discard product feedback from non-disappointed survey respondents
“You should discard the feedback that you receive from the users who would not be disappointed if they could no longer use your product. They're not really your target market or your audience, so it's best to just politely thank them for their feedback and shif…”
Erickson: Early-stage founders should prioritize low dilution over high valuations
“So I would say in the early stages, at least, don't worry too much about valuation. It's a good idea to keep an eye on dilution, but it's better to raise less at a lower valuation and a lower dilution than to raise at a larger amount at a high valuation early …”
Regulatory shifts forced Eaze in and out of product-market fit
“Ease had product market fit in the previous market, medical only, but in 2018 we had to deal with both a changing market and regulations that forced us to change our delivery model. We spent the next couple of years moving in and out of product market fit, whi…”